COMP <GO>
PRKS vs GENI // RSI-14 & 200D SMA MOMENTUM
United Parks & Resorts Inc. (NYSE) VS. Genius Sports Limited (NYSE) • 15-METRIC TALLY: PRKS 5
— GENI 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: GENI
LAST: $31.61 (+1.97%) • MKT CAP: $1.43B
rsi-technicals
39.3
LAST: $6.46 (+1.73%) • MKT CAP: $1.73B
rsi-technicals
48.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRKS VS. GENI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRKS | GENI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 23.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.20% | -26.90% | +44.10 | PRKS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 11.34% | 3.73% | +7.61 | PRKS | /fcf-yield <GO> |
| Operating Margin | 22.00% | -22.60% | +44.60 | PRKS | /operating-margins <GO> |
| Net Profit Margin | 10.10% | -16.70% | +26.80 | PRKS | /net-margins <GO> |
| Revenue Growth (YoY) | -3.60% | 31.00% | -34.60 | GENI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.76 | 1.43 | +0.33 | PRKS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | GENI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 39.3 | 48.2 | -8.86 | GENI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 7.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.43B | $1.73B | -$295.6M | GENI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRKS REV | GENI REV | PRKS GROSS % | GENI GROSS % | PRKS FCF | GENI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.66B | $669.5M | — | 23.0% | $162.6M | $64.5M |
| FY 2024 | $1.73B | $510.9M | — | 25.2% | $231.7M | $69.6M |
| FY 2023 | $1.73B | $413.0M | — | — | $504.9M | $14.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRKS // BETA —
GENI // BETA —